Medical College of Georgia
Augusta, Georgia, 30912, United States
NCT Number: NCT00070889
Patients experiencing a first episode of psychosis may have brain cell damage due to a chemical process called oxidation. This study will compare patients with psychosis to healthy volunteers to determine if there are differences in their blood that reflect oxidative brain cell damage.
Looking for future studies?
Notify Me12 year–45 year
All sexes
Observational
Augusta, Georgia, 30912, United States
Preliminary research indicated that impaired antioxidant defense and increased lipid peroxidation is associated with brain changes during the onset of psychosis. Oxidative cell injury may contribute to poor outcomes in some patients. This study will define the extent and nature of oxidative cell injury that is associated with psychopathology at the onset of psychosis.
Participants in this study will be patients at the D. D. Eisenhower Army Medical Center who are experiencing a psychotic episode for the first time. Patients will be compared with 40 healthy volunteers (control group) matched with patients for age, gender, education, ethnic background, and occupational status. Patients and volunteers will have blood tests to determine the level of oxidative cell injury. Tests will be performed at onset of psychosis, and after 6 and 12 weeks of neuroleptic drug treatment. Medical histories and MRI scans will be used to examine the relationship of the laboratory tests to the clinical presentation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
National Center for Complementary and Integrative Health (NCCIH)
Nih
Oxidative Cell Injury: First Episode Psychotic Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06960811
Brain Diseases, Central Nervous System Diseases
Nancy, Lorraine, France
View Trial DetailsNCT03609515
Affective Disorder, Mental Disorders
View Trial DetailsNCT00204061
Mental Disorders, Pathological Conditions, Signs and Symptoms
Cologne, North Rhine-Westphalia, Germany
View Trial DetailsNCT01196858
Affective Psychosis, Bipolar, Bipolar Disorder
Bodø, Bodoe, Norway
View Trial Details